Hyperglycemia augments formation of intracellular reactive oxygen species (ROS) with associated mitochondrial damage and increased risk of insulin resistance in type 2 diabetes. We examined whether quercetin could reverse chronic high glucose-induced oxidative stress and mitochondrial dysfunction. Following long-term high glucose treatment, complex I activity was significantly decreased in isolated mitochondria from HepG2 cells. Quercetin dose-dependently recovered complex I activity and lowered cellular ROS generation under both high and normal glucose conditions. Respirometry studies showed that quercetin could counteract the detrimental increase in inner mitochondrial membrane proton leakage resulting from high glucose while it increased oxidative respiration, despite a decrease in electron transfer system (ETS) capacity, and lower non-ETS oxygen consumption. A quercetin-stimulated increase in cellular NAD + /NADH was evident within 2 h and a two-fold increase in PGC-1α mRNA within 6 h, in both normal and high glucose conditions. A similar pattern was also found for the mRNA expression of the repulsive guidance molecule b (RGMB) and its long non-coding RNA (lncRNA) RGMB-AS1 with quercetin, indicating a potential change of the glycolytic phenotype and suppression of aberrant cellular growth which is characteristic of the HepG2 cells. Direct effects of quercetin on PGC-1α activity were minimal, as quercetin only weakly enhanced PGC-1α binding to PPARα in vitro at higher concentrations. Our results suggest that quercetin may protect mitochondrial function from high glucose-induced stress by increasing cellular NAD + /NADH and activation of PGC-1α-mediated pathways. Lower ROS in combination with improved complex I activity and ETS coupling efficiency under conditions of amplified oxidative stress could reinforce mitochondrial integrity and improve redox status, beneficial in certain metabolic diseases.
Introduction
Hyperglycemia is characteristic of type 2 diabetes and the metabolic syndrome, where high levels of glucose in the blood lead to intracellular oxidative stress, especially in tissues involved in glucose metabolism [1] [2] [3] . Although mitochondria are a source of oxidative stress, they are also a principal target of attack by reactive oxygen and nitrogen species [4, 5] and, once above certain thresholds, insulin sensitivity and secretion are hampered [6, 7] . Complex I of the electron transfer system (ETS) is a major source and target of mitochondrial superoxide generation [8, 9] and is therefore central to high glucose-induced oxidative stress [1, 10] , while surplus glucose and accumulating NADH can overload complex I and cause excess superoxide generation [1, 11] . Associated mitochondrial dysfunction exacerbates the stress further in a downward spiral linked with a perturbation in glucose and lipid oxidation [10] [11] [12] [13] [14] . The cause-effect relationship between mitochondrial dysfunction and insulin resistance is still debated [15] , but it is likely they both occur at least in part as a result of the high glucose stress.
Quercetin is a well-studied flavonoid that transiently accumulates in mitochondria [16] following rapid passive cellular uptake or local de-conjugation of quercetin metabolites, especially at sites of inflammation [17] [18] [19] . Quercetin has been shown to exert an effect on mitochondrial function both directly and indirectly through signalling pathways associated with biogenesis, metabolic flux, respiration, mitochondrial membrane potential and apoptosis [16, 20, 21] . Studies in rat pancreatic cells suggest quercetin can improve mitochondrial bioenergetics by increasing respiration coupling efficiency [22] while in primary cortical neuronal cells quercetin enhanced respiratory capacity and cell survival [23] . Quercetin has also been shown to stimulate mitochondrial metabolic signalling pathways [23] , and to increase PGC-1α, NRF-1 and TFAM mRNA both in HepG2 cells and mouse primary hepatocytes [24, 25] .
At the same time quercetin and other flavonoids are also known to influence glucose in the intestine through modulation of carbohydrate digestion and absorption [26] [27] [28] and thus affect hepatic glucose, and expression of glycolytic genes in the liver [29] . In streptozotocin-induced diabetic rats, quercetin dose-dependently decreased blood glucose, cholesterol and triglycerides [30] alongside hepatic oxidative stress markers [31] , while it increased hepatic glucokinase activity [30] . Such bioactivities have attracted research in the potential application of quercetin in the prevention and management of type 2 diabetes [32, 33] , but data on its mechanism of action in high glucose stress environments is lacking.
The majority of previous in vitro studies examining the effects of quercetin on mitochondria have often employed acute treatments directly to isolated organelles [34] [35] [36] , and overlooked longer-term effects in intact cells. In isolated rat brain mitochondria, quercetin lowered hydrogen peroxide production and inhibited complex I, while the latter was reversed by addition of coenzyme Q 10 (CoQ) [34] . In comparison, in isolated mitochondria from rat duodenum quercetin protected complex I from inhibition by non-steroidal anti-inflammatory drugs, suggesting a CoQ-like function [35] . To enhance understanding of the role of quercetin on maintaining mitochondrial function, we evaluated its dose-dependent effects, following chronic application of up to 24 h, on mitochondrial respiration in an immortalized human hepatic cell model stressed by chronic high glucose.
Several studies have linked cancer phenotype progression, generally relying on fast glucose turnover and glycolysis, with expression levels of repulsive guidance molecules (RGM) [37] [38] [39] . The biological function of RGMs, a recently discovered family of glycosylphosphatidylinositollinked cell-membrane-associated proteins, remains largely elusive but recent work has unveiled a discrete tissue-specific pattern of gene and protein expression for each member (a, b, c) [37] . RGMB is specifically thought to regulate respiratory immunity, while its long non-coding RNA (lncRNA) RGMB-AS1 is lowly expressed in hepatocellular carcinoma tissues and cell lines [40, 41] and, as such, gain-of-function studies showed that up-regulation of lncRNA RGMB-AS1 suppressed proliferation, migration and invasion of hepatocellular carcinoma cells such as HepG2 and promoted cell apoptosis [40] . The effects of quercetin on RGMB and RGMB-AS1 are yet to be determined. We demonstrate a link between oxidative signalling pathways and changes in mitochondrial respiration and metabolic phenotype in the glycolytic environment of HepG2 cells following chronic quercetin treatment, with an associated effect on RGMB(-AS1).
Materials and methods

Chemical compounds and reagents
All cell culture medium components, quercetin 3-O-β-D-glucuronide and other reagents were from Sigma-Aldrich (Gillingham, UK) unless otherwise stated. Quercetin was from Extrasynthese (Genay, France) and quercetin 3′-O-sulfate was synthesised in house [42] . TrypLE Express and Pierce Coomassie (Bradford) Protein Assay Kit (#23200) were from Thermo Fisher Scientific (Paisley, UK). Mouse anti-NDUFB8 (ab 110242) was from Abcam (Cambridge, UK) and NADH was from VWR (Lutterworth, UK).
FAM-labelled Taqman primers for PPARGC-1α (PGC-1α, Hs01016719_m1), Repulsive guidance molecule b (RGMB, Hs00543559_m1), RGMB antisense RNA 1 (RGMB-AS1, Hs04273852_m1) and VIC-labelled primer for TATAbox binding protein (TBP) primer (Hs00427620_m1) were from Life Technologies (Thermo Fisher Scientific). Droplet digital PCR (ddPCR) Supermix for Probes (no dUTP) and all other materials used for ddPCR were from BioRad (Watford, UK). High purity water (18.2 MΩ cm −1 ) supplied by a MilliQ system (Merck Millipore UK, Watford, UK) was used throughout this work.
Cell culture
HepG2 cells purchased from the American Type Culture Collection (HB-8065, LGC Promochem, Teddington, UK) were maintained in Eagle's minimum essential medium (EMEM) containing 5.5 (normal) or 25 mM (high) glucose, supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, 100 mg/ml streptomycin, 2% (v/v) non-essential amino acids, and 1% (v/v) sodium pyruvate. Cells were seeded in 75 cm 2 flasks, 6-well or 24-well plates (Appleton Woods, UK) at 8 × 10 4 cells cm −2 and kept in a humidified atmosphere of 5% CO 2 /95% air at 37°C. The EMEM medium was supplemented with additional glucose and filtered through a 0.2 µm PTFE filter (Corning, UK) for high glucose conditions. 
Trypan Blue exclusion cell viability assay
Isolation of submitochondrial particles
HepG2 cells were seeded in 75 cm 2 flasks and grown in normal or high glucose for 96 h. Cells were treated with 2.5, 5, 10 or 20 µM quercetin (or 0.1% DMSO controls) for the final 24 h, scraped into 1 ml PBS supplemented with 1% (v/v) protease inhibitor cocktail (P8340, Sigma-Aldrich, UK), centrifuged at 210×g (4°C, 5 min) and snap-frozen in ethanol over dry ice. Cell pellets were stored at −80°C until mitochondrial isolation. Submitochondrial particles were prepared from thawed cell pellets following three freeze-thaw cycles [43] [44] [45] , homogenisation with a Dounce homogenizer and differential centrifugation using the Mitochondria Isolation Kit for Cultured Cells (ab 110171, Abcam, UK) following the manufacturer's protocol guidelines but with an extra centrifugation step (1000×g, 4°C, 5 min) at the end, for a purer preparation. Mitochondrial pellets were resuspended in 250 mM sucrose, 10 mM HEPES, 50 mM Tris buffer (pH 7.4) supplemented with 1% (v/v) protease inhibitor cocktail.
Submitochondrial fraction purity assessment
Aliquots of the initial cell lysate and the isolated submitochondrial particles of HepG2 cells were analysed for NDUFB8 (a subunit of complex I) levels by ProteinSimple Wes automated western blotting (ProteinSimple, Bio-Techne, CA, USA) according to the manufacturer's guidelines. Samples were denatured at 37°C for 20 min and applied at 4.8 mg protein /ml with primary mouse anti-NDUFB8 at 1/50 dilution and chemiluminescence detected in the multi-image analysis mode. Data are presented as chemiluminescence peaks and in the traditional Western gel-like image view (Compass Software, Bio-Techne).
Complex I activity assay
Submitochondrial particles from HepG2 cells grown in normal or high glucose for 96 h and treated with varying concentrations of quercetin for the final 24 h were isolated as described above and assayed for complex I specific activity spectrophotometrically in 96-well plates on a PheraSTAR FS microplate reader (BMG LabTech, Germany) at 37°C. Submitochondrial particles (10 µg) were mixed with 150 µM NADH and 50 µM coenzyme Q 1 (analog of coenzyme Q 10 ) and the decrease in absorbance at 340 nm was followed for 60 min, as previously described [44] [45] [46] [47] [48] following optimisation for sample mass and NADH/ CoQ1 concentrations. Specific activity was calculated by converting rate of absorbance change into rate of NADH decrease per mg of total protein [43] and expressed as % of normal glucose (0.1% DMSO control).
DCFH-DA assay
HepG2 cells were grown in 6-well plates for 96 h in normal or high glucose and treated for the final 2, 12 or 24 h with 2.5, 5, 10 or 20 µM quercetin (or 0.1% DMSO controls). The DCFH-DA assay was used to assess oxidative stress as described before [49] , but with the following modifications. Cells were washed with PBS, incubated with 10 µM DCFH-DA in PBS (37°C, 20 min in darkness), washed again and fluorescence of DCF was measured on the PheraStar FS microplate reader (BMG LabTech, Germany; Ex/Em = 485/530 nm). Cells were scraped in CellLytic M supplemented with 1% (v/v) protease inhibitor cocktail and total protein was measured with the Bradford assay [50, 51] . DCF fluorescence, in relative fluorescence units, was corrected for protein and expressed as relative DCF fluorescence % in the normal/high glucose controls accordingly. 
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Citrate synthase activity assay
Cells were grown in 75 cm 2 flasks in normal or high glucose for 96 h, with 10 or 20 µM quercetin (or 0.1% DMSO controls) for the final 24 h. Cell pellets, prepared as above for mitochondria isolation, were lysed and assayed for citrate synthase activity, a marker for total mitochondrial content [52] , using the Citrate Synthase Assay Kit (CS0720, Sigma-Aldrich) and following the manufacturer's instructions. Briefly, formation of the 5-thio-2-nitrobenzoic acid colorimetric reaction product was followed on the PheraStar FS microplate reader at 412 nm (30°C, 5 min) and again after addition of oxaloacetic acid. Citrate synthase activity was calculated by correcting for the initial reaction rate, a baseline of endogenous thiol/deacetylase levels, and for total protein prior to the assay.
High-resolution respirometry
HepG2 cells, treated as for the citrate synthase assay, were washed in PBS, lifted from 75 cm 2 flasks using TrypLE Express and resuspended in serum-free medium at 1.5 × 10 6 cells/ml. Oxygen concentration and flux were continuously measured following addition of 2 ml of the cell suspensions to each chamber of the Oxygraph-2k (O2k) (OROBOROS Instruments, Innsbruck, Austria), maintained at 37°C. A phosphorylation control protocol was followed [53, 54] . Routine respiration was initially recorded, followed by Leak measurement after addition of 250 nM oligomycin; titration with FCCP (carbonyl cyanide-4-(trifluoromethoxy)-phenylhydrazone) (5 µM, 3-5 µl) for ETS capacity; and addition of 1.25 µM rotenone and 2.5 µM antimycin A for assessment of residual oxygen consumption (ROX). Additional experiments were conducted whereby quercetin (10-100 µM) was titrated directly into the respirometer chamber containing a HepG2 cell suspension, followed by FCCP positive control, to assess if quercetin was acting as a direct ETS uncoupler. As a control for the effect of quercetin reacting directly with oxygen, quercetin (10-200 µM) was also titrated into cell-free medium.
Cellular NAD + /NADH assay
Cells were grown in 24-well plates and treated as described above for the DCFH-DA assay. Cells were washed in PBS, lysed and collected, and NAD + /NADH was measured using a Fluorometric Assay Kit (ab 176723, Abcam, UK), in which enzymes specifically recognise NAD + or NADH in an enzyme cycling reaction. According to manufacturer's instructions, lysates were transferred to a black, clear-bottomed 96-well plate (Greiner Bio-One, Stonehouse, UK) and, after incubation for 60 min at RT, fluorescence signals were collected on the PheraSTAR FS (Ex/Em = 540/590 nm).
RNA isolation and cDNA synthesis
Cells were grown in normal or high glucose in 6-well dishes for 60 h. At 60 h cells were transferred to medium ± FBS for 12 h (72 h) before treatment with 20 µM quercetin (or 0.1% DMSO controls) for up to a further 24 h. Samples were collected after 1, 3, 6, 12 and 24 h. Additional samples were collected at 60 h (-12 h) and 72 h (time 0) in order to assess whether the absence of FBS had an effect on mRNA expression. Total RNA was isolated using the Aurum Total RNA Mini Kit (#732-6820, Bio-Rad Laboratories, UK) and following the manufacturer's instructions. RNA content was determined spectrophotometrically at 260 nm on a NanoDrop (Thermo Fisher Scientific) and cDNA was synthesised from 1 µg RNA using a High Capacity RNA-to-cDNA kit (Applied Biosystems, Thermo Fisher Scientific), following the manufacturer's guidelines. 
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Droplet digital PCR analysis
The QX100 Droplet Digital PCR system (Bio-Rad Laboratories, USA) was used to quantify changes in gene expression of PGC-1α, RGMB, RGMB-AS1 and TBP (housekeeping gene) as previously described [55] . Primers of PGC-1α, RGMB, RGMB-AS1 were mixed with TBP Taqman primer in a 20 µl assay (1 µl of each) that contained 10 µl of ddPCR Supermix and 8 µl of cDNA diluted with MilliQ water. The mixtures were dispersed into oil droplets using the QX100 Droplet generator and then transferred to a C1000 Touch thermal cycler (Bio-Rad Laboratories, USA). Droplet-containing mixtures were incubated for 10 min at 95°C, followed by 40 cycles of 0.5 min at 94°C and 1 min at 57.8°C, and finished with 10 min incubation at 98°C. Products were maintained at 12°C before analysis on a QX100 Droplet Reader. The QuantaSoft software (Košice, Slovakia) was used to analyse the data and determine concentrations of the target DNA in copies per µl from the fraction of positive reactions using Poisson distribution analysis. Data were collected independently for each target and TBP and are presented as foldchange of control treatment.
PPARα coactivator recruitment assay
The potential of quercetin to bind to PPARα and affect coactivator (PGC1-α) recruitment was tested both in the agonist and antagonist mode with a LanthaScreen TR-FRET (time-resolved fluorescence energy transfer) assay (#PV4684, Invitrogen, Thermo Fisher Scientific, UK) according to supplier's guidelines. Briefly, PPARα ligand binding domain tagged with glutathione-S-transferase (GST) was added either to GW7647 (PPARα agonist positive control), GW9662 (antagonist positive control), quercetin, quercetin 3′-O-sulfate or quercetin 3-O-β-Dglucuronide, followed by the addition of pre-mixed fluorescein-PGC-1α coactivator peptide (in 50 mM HEPES, pH 7.5) and LanthaScreen terbium-labelled anti-GST antibody (in 137 mM NaCl, 2.7 mM KCl, 10 mM HEPES, pH 7.5). Following optimisation by comparison of achieved Z´ values, calculated by using the "maximum agonist" or "maximum antagonist" and "no agonist" or "no antagonist" control data [56] 
Statistical analysis
Data are expressed as means ± standard error of the mean. The significance of differences between groups of treatments was analysed by one-way ANOVA and post hoc Tukey's, Dunnett's or two-tailed t-tests as indicated, with variance checks using Levene's test, and with Bonferroni correction when multiple treatments were compared with an independent samples Student t-test, using SPSS 24.
Results
Quercetin restores complex I activity compromised by chronic high glucose stress
The mitochondria isolation procedure yielded a highly purified fraction as confirmed by NDUFB8 (a subunit of complex I) expression (Fig. 1A) . Complex I activity, as assessed by NADH oxidation in mitochondria isolated from HepG2 cells (Fig. 1B) , decreased by 11% (p < 0.001) following high glucose for 24 h and by 19% (p < 0.001) after 96 h when compared to control cells. Both hydrogen peroxide and serum absence also decreased complex I activity, while, as expected, it was higher in cells grown in galactose-containing medium (Fig. 1C-D) . In normal glucose, quercetin treatment (2.5-20 µM) caused a small decrease in complex I activity, comparable in all tested concentrations. However, in high glucose, quercetin up to 10 µM dose-dependently attenuated the high glucose-induced damage; a 94% recovery was found with 10 µM (p < 0.001) while at 20 µM the effect was less pronounced (Fig. 1E) .
Quercetin lowers concentration of several ROS species in normal and high glucose
High glucose treatment for 96 h increased DCF fluorescence by 10% (p < 0.01) ( Fig. 2A) , indicating higher levels of some ROS species and an environment with increased oxidative stress. This was attenuated in both normal and high glucose conditions dose-dependently by quercetin (2.5-20 µM) at all the time points tested, up to 24 h (Fig. 2B-D) . The effect of quercetin on DCF fluorescence was most evident at earlier time points, with a maximum lowering effect of 53% in normal (p < 0.001) and 57% in high glucose (P < 0.001) after treatment with 20 µM quercetin for 2 h (Fig. 2B) . This highly significant decrease of 45% in the DCF fluoresce signal in both normal and high glucose conditions is indicative that some ROS species were decreased, and this decrease was not significantly different between normal and high glucose with any dose of quercetin at 2 h (Fig. 2B) . Quercetin effects were less evident at later time points, particularly in the high glucose (Fig. 2C-D) . Although we observed changes at 2.5 μM and above, in 
M.J. Houghton et al. Free Radical Biology and Medicine 129 (2018) 296-309
subsequent experiments we chose to test 10 and 20 μM quercetin to clarify the mechanism of protection against high glucose.
Quercetin decreases mitochondrial content while increasing cell viability
Growing cells in normal or high glucose did not affect citrate synthase activity, a mitochondrial matrix marker, whereas quercetin significantly lowered citrate synthase activity after 24 h in normal glucose at 10 and 20 µM by 5% and 7% (p < 0.05) respectively. In high glucose an effect was observed only with the 20 µM treatment (5%, p < 0.05) (Fig. 3A) . Cell viability, assessed by Trypan Blue exclusion, was also not affected by glucose but dose-dependently increased by quercetin, by up to 5% in high glucose (p < 0.001) (Fig. 3B) .
Quercetin lowers high glucose-induced proton leak and increases oxidative respiration
Inner mitochondrial membrane (IMM) proton leak, was 21% (p < 0.05) higher in high glucose-treated cells, which was reflected in lower coupling efficiency (p < 0.01), but without significant changes in basal Routine respiration, non-coupled ETS capacity, or non-ETS residual oxygen consumption (ROX). Despite less efficient coupling, mitochondrial ATP production was unaffected (Fig. 4B) . Respiration in normal glucose was unchanged by quercetin, but Leak was hermetically suppressed (p < 0.01) and coupling efficiency was higher with 10 µM accordingly (p < 0.05) (Fig. 4C) . Quercetin treatment dose-dependently reversed the high glucose-induced proton Leak (p < 0.01) (Fig. 4D ) while 10 µM quercetin also increased oxidative respiration, both the basal cellular and the oligomycin-sensitive 'Net' mitochondrial respiration (calculated from (Routine-Leak)/ETS) (p < 0.01). Moreover, mitochondrial ATP production was enhanced (p < 0.01) and coupling efficiency recovered (p < 0.001) (Fig. 4D) . A similar effect was not evident with 20 µM quercetin treatment (Fig. 4D) . In general, following quercetin treatment, ETS capacity was either unchanged (normal glucose, 10 µM quercetin) or mildly lower (both in normal and high glucose), and ROX was dose-dependently decreased in both normal and high glucose (Fig. 4C-D) .
Quercetin does not uncouple mitochondrial respiration
When added directly to cell-free medium in the respirometer, quercetin dose-dependently reacted with oxygen (Fig. 5A) . When added to HepG2 cells in suspension and equilibrated in the respirometer chamber, the increase in oxygen consumption was no longer evident, indicating quercetin did not react with oxygen in the medium in the presence of the cells, but was rather rapidly taken up. In the cellular environment quercetin did not act as a direct ETS uncoupler, unlike FCCP (Fig. 5B) .
Quercetin reversed the decreased NAD + /NADH in high glucose within 2 h
High glucose increased cellular NADH (p < 0.001) (Fig. 6A ), but this was blunted at later time-points. Quercetin dose-dependently increased NAD + /NADH in high glucose after 2 h (p < 0.01), but not in normal glucose (Fig. 6A) . NAD + /NADH was elevated after 12 h with 10 µM quercetin in both normal and high glucose (p < 0.001) (Fig. 6B ) and this effect was maintained in normal glucose up to 24 h (p < 0.001) (Fig. 6C) . In high glucose, an effect was evident with 20 µM quercetin at 24 h (p < 0.05).
Quercetin increased PGC-1α, RGMB and RGMB-AS1 mRNA
Absence of serum increased PGC-1α mRNA expression under both normal and high glucose conditions (Fig. 7A, C) while RGMB and RGMB-AS1 mRNA levels were not affected by either (Figs. 9 and 10-panels A, C). Following 12 h in serum-free medium (time 0) PGC-1α increased by 1.7-fold (p < 0.001) and remained stable for 12 h in normal glucose before returning to basal levels by 24 h (Fig. 7A) . In the presence of high glucose a further increase was evident at 6 h (2-fold), while at 24 h mRNA levels were significantly lower than in control cells (Fig. 7C) . Treatment with 20 µM quercetin increased PGC-1α gene expression within 1 h in normal glucose (p < 0.001) and within 6 h in high glucose (p < 0.001). A maximal approximately 2-fold effect was reached at 6 h in both normal and high glucose (Fig. 7E, G) . Quercetin increased RGMB mRNA~5-fold after 3 h (p < 0.001) (Fig. 9E, G) and RGMB-AS1~3.5-fold after 6 h (p < 0.001) (Fig. 10E, G) , similarly in normal and high glucose. Increased mRNA levels of RGMB and RGMB-AS1 were maintained for at least 12 h. As the droplet digital PCR technique determines the absolute number of mRNA molecules in the reaction, employing a stably expressed reference gene is not essential but TBP was used to account for variations in the sample preparation and to provide comparison between different conditions. TBP was mildly affected by the absence of serum and the high glucose conditions and therefore was reported separately (Figs. 7, 9, 10 . PGC-1α and TBP mRNA levels following quercetin treatment (E-H). Cells were seeded in normal (NG) or high (HG) glucose media and after 60 h (T = -12 h) the medium was changed to medium ± FBS (F). Cells were treated at 72 h (T = 0 h) with ± FBS and lysates for RNA extraction were collected at 6, 12 and 24 h, with additional at −12 and 0 h. (E-H) Cells were grown in the same way and treated with serum-free medium from 60 h and with 20 µM quercetin (Q) at 72 h (T = 0 h) (or DMSO controls), and samples were collected at 1, 3, 6, 12 and 24 h. All data are mean values of foldchange in PGC-1α or TBP expression ± SEM (N/n = 6/18) vs respective controls. *p < 0.05, **p < 0.01, ***p < 0.001 vs respective control.
Quercetin does not affect PPARα coactivator recruitment of PGC1-α
A TR-FRET assay was set up to test if quercetin could directly affect binding of PGC-1α to PPARα. The assay was able to detect binding interactions with high sensitivity and small variability; a Z′ of 0.851 and an EC 50 of 1.057 nM was measured for GW7647 (Fig. 8A) , and a Z´ of 0.689 and an IC 50 of 443.6 nM for GW9662 (Fig. 8B) , a known agonist and antagonist of PPARα respectively. Quercetin was found to exert only minimal effects in the agonist mode at ≥ 10 µM (p < 0.01) (Fig. 8C) , while it had no effect as an antagonist (Fig. 8D ). An EC 50 was not calculated for quercetin because for the concentrations tested a plateau was not reached (Fig. 8C) . Quercetin conjugates, quercetin 3′-O-sulfate and quercetin 3-O-β-D-glucuronide, were weaker agonists than quercetin aglycone; an increase in fluorescence emission was measured only at ≥ 100 µM (p < 0.01) (Fig. 8C ).
Discussion
High glucose-induced oxidative stress is linked to mitochondrial dysfunction, insulin resistance and metabolic syndrome [57] . Quercetin is thought to have a beneficial effect in various aspects of these metabolic diseases [20, 25, 31, 32, 58] , either through restriction of ROS generation locally, or enhancement of cellular oxidative defences [34, [59] [60] [61] [62] . Mechanisms of quercetin action have been reviewed [20] and it is apparent that information in the high glucose environment, and on longer term metabolic effects, remains limited.
Under conditions of chronic high glucose, serum starvation, or increased oxidative stress following treatment with H 2 O 2 , ETS complex I activity was decreased in agreement with previous reports [63, 64] , while activity was increased by galactose, owing to increased oxidative phosphorylation fuelled by glutamine and fatty acids [65] [66] [67] [68] . We show here that quercetin could dose-dependently protect against accumulating ROS and preserve the ETS protein complexes, potentially halting damage in mitochondrial DNA that ultimately occurs [4, 5, 8, 69] . We found that quercetin was able to relieve complex I from ROS-induced damage, especially under high glucose stress. Competitive inhibition of complex I at the CoQ-binding site was previously reported for quercetin [70] as well as a complementary activity as a CoQ mimetic, allowing electron transfer to continue from NADH to complex III [34, 35, 71] . Quercetin effects were time-dependent, probably due to quercetin metabolism, although sustained effects following 24 h after quercetin treatment point to metabolic changes. It has been shown that quercetin is almost fully metabolised within 4 h in HepG2 cells, while phase II metabolism was attenuated by high glucose [72] . We observed effects here even at 2.5 μM quercetin, although many of the mechanistic experiments were performed at 10 μM to ensure confidence in the results. Most previous publications cited in this paper have used much higher concentrations of quercetin. Ultimately, proof of any effect must be shown in vivo, but it is helpful to understand the mechanistic aspects using cultured cells.
A mild but significant decrease in citrate synthase activity was observed by quercetin treatment in both normal and high glucose while cell viability and plasma membrane integrity were improved. Since high glucose-induced loss of complex I activity was reversed with quercetin, this indicates improved mitochondrial function and increased oxidative capacity, limiting aberrant cell proliferation, a characteristic of glycolytic HepG2 cells. These results were also corroborated by increased RGMB and lncRNA RGMB-AS1 expression, which were previously correlated with decreased HepG2 proliferation and formation of a smaller number of colonies [40] . RGMb is also thought to reflect respiratory immunity in epithelial cells through binding to programmed death ligand 2 (PD-L2), while blockade of the RGMB-PD-L2 interaction markedly impaired the development of respiratory tolerance [41] . Lowered mitochondrial content is likely owed to decreased lipogenesis and membrane formation, with pyruvate being directed to citrate and to oxidative metabolism rather than lipid anabolism; with increased oxidative function the mitochondrial population is streamlined.
Our hypothesis is also supported by lower proton leak across the IMM and an overall decrease in DCF fluorescence, albeit the latter is not Quercetin had no effect as an antagonist at the tested concentrations (0.6-100 µM). All data are mean (N/n = 3/18) and error bars represent SEM. exclusively indicative of ROS alone nor informative of specific ROS species formed [73] , but limitations in this assay are outweighed by the highly significant differences observed in cells treated with quercetin and the decrease is associated with the general change in redox status and lower oxidative stress. Previous studies have shown that quercetin improves mitochondrial bioenergetics in various other models [22, 23] , while a role in maintaining membrane integrity has also been hypothesized [74] [75] [76] . The lower Leak in high glucose-treated cells with quercetin led to enhanced mitochondrial respiration by maximizing coupling efficiency and was reflected in higher Routine and net ETS respiration, indicative of increased use of ETS capacity for ATP turnover [54] as found here. These changes were only evident in the cells treated with 10 µM quercetin, while at 20 µM there was a decrease in routine respiration, consistent with the hypothesis that complex I may have been inhibited. Previous studies suggested that quercetin uncoupled ETS and oxidative phosphorylation while inhibiting mitochondrial respiration in isolated mitochondria [77] [78] [79] . In intact H9c2 rat cardiomyocytes short-term incubation with quercetin did not induce uncoupling, demonstrating that the effects seen in isolated mitochondria are attenuated in whole cells [80] . We provide supporting evidence for this here, as quercetin at high concentrations did not act as an uncoupler in HepG2 cells. When cells were not present, quercetin reacted with oxygen [81] .
Importantly, the non-ETS residual oxygen consumption (ROX) was dose-dependently decreased by quercetin, which is indicative of less dependence on glycolysis. ROX represents the combined effect of oxygenase redox enzymes [54, 82, 83] and cell surface oxygen consumption via trans-plasma membrane electron transport (tPMET) [84] . Increased NADH oxidation by the actions of quercetin, as shown here by an increase in the NAD + /NADH ratio, and via direct inhibition of ATPase enzymes [85] [86] [87] [88] such as those involved in tPMET could explain our results. Lower dependence on glycolysis would be expected if more ATP is generated by quercetin-enhanced mitochondrial respiration and oxidation of alternative substrates such as glutamine and fatty acids [53] , as shown here after 24 h.
Furthermore, quercetin inhibited glucose-6-phosphatase in insulinresistant HepG2 cells and enhanced insulin sensitivity, allowing glycolysis to continue towards pyruvate [89] . We previously showed that 5 µM quercetin had a modest inhibitory effect on glucose uptake and metabolism in HepG2 cells over 12 h in normal glucose conditions [90] . However, HepG2 cells are known to be highly glycolytic with compromised oxidative phosphorylation, limited PI3K-Akt signalling and insulin responses [91] . A sustained decrease in ROS would potentially enhance insulin sensitivity in cells in vivo, although this possibility is difficult to explore in immortalized cell models where glucose transport is mainly governed by GLUT1 and to a much lesser extent by insulinresponsive GLUT transporters.
A quercetin-induced increase in cellular NAD + could give rise to posttranslational modifications through the AMPK-SIRT-PGC-1α axis, a central regulator of energy metabolism. PGC-1α has been linked to mitochondrial biogenesis and function while it is also activated under oxidative stress [92] [93] [94] , and thought to suppresses transcription of glycolytic genes [95] . PGC-1α mRNA was increased in response to serum deprivation and further increased by quercetin under both normal and high glucose conditions, indicating that glucose concentration is not the critical effector in PGC-1α induction by quercetin. An increase in PGC-1α transcription corroborates the observed increase in NAD + in cells treated with quercetin, as NAD + -dependent SIRT1 activates PGC-1α, which in turn promotes its own transcription [96, 97] .
Given that quercetin was found to only weakly enhance PGC-1α recruitment to PPARα, the main upstream nuclear factor regulating genes involved in mitochondrial energy metabolism, at concentrations probably not achievable in the cellular environment, we conclude that the effects of quercetin on PGC-1α are most likely via indirect mechanisms and a result of the effects seen on complex I and NADH as summarized in Fig. 11 . However, we cannot exclude involvement of other transcription factors in the transcriptional regulation of PGC-1α by quercetin.
The protective effects of quercetin on mitochondrial bioenergetics in cells stressed by high glucose have not been demonstrated previously. Proteomics studies have revealed that complex I is lowered in diabetic patients [98] , providing a potential target for the protective effects of quercetin against developing type 2 diabetes, as observed in epidemiological studies for quercetin-rich foods such as apples and tea [99, 100] and for quercetin in animal models of diabetes [101, 102] . The notable quercetin-induced increases in RGMB and RGMB-AS1 in HepG2 cells point towards a potential mechanism in the disruption of cancer cell proliferation [40] , linked to the alteration from high dependence on glycolysis. •-) at complex I of the electron transfer system. (B) Quercetin inhibits complex I at the coenzyme Q 10 -binding site (CoQ), suppresses superoxide generation and attenuates the high glucose-induced proton leak across the inner mitochondrial membrane, while oxidising NADH and potentially allowing electron transfer to continue to complex III. This results in more efficient coupling with ATP synthesis. As a result, the NAD + /NADH ratio is increased in parallel with induction of PGC-1α gene expression by quercetin; mitochondrial function is promoted and metabolic flux shifted to mitochondrial respiration, leading to lower oxidative stress and attenuation of high glucose-induced mitochondrial dysfunction, with increased net respiration and recovered complex I activity. RGMB and RGMB-AS1 (not shown) were increased with PGC-1α in correlation with the shift from glycolysis. PDH -pyruvate dehydrogenase, TCA cycle -tricarboxylic cycle, Acetyl CoA -acetyl coenzyme A.
